Cargando…

LncRNA SNHG3 enhances the malignant progress of glioma through silencing KLF2 and p21

As a newly discovered long non-coding RNA, small nucleolar RNA host gene 3 (SHNG3) has been reported to be dysregulated in certain cancers. Nevertheless, the details about clinical values and biological effects of SNHG3 on glioma are still covered. In this paper, we determined the expression level o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fei, Fan, He, Yongsheng, He, Sen, He, Zhongze, Wang, Youyu, Wu, Gang, Li, Mengni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2018
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127675/ https://www.ncbi.nlm.nih.gov/pubmed/30042166 http://dx.doi.org/10.1042/BSR20180420

Ejemplares similares

Retraction: LncRNA SNHG3 enhances the malignant progress of glioma through silencing KLF2 and p21
Publicado: (2021)

Expression of Concern: LncRNA SNHG3 enhances the malignant progress of glioma through silencing KLF2 and p21
Publicado: (2020)

Epigenetic silencing of ZCCHC10 by the lncRNA SNHG1 promotes progression and venetoclax resistance of acute myeloid leukemia
por: Zhou, Hao, et al.
Publicado: (2023)

LncRNA SNHG6 Silencing Could Arrest Progression of High Grade Colorectal Cancers
por: Jafari-Oliayi, Amin, et al.
Publicado: (2022)

LncRNA SNHG16 Aggravates High Glucose-Induced Podocytes Injury in Diabetic Nephropathy Through Targeting miR-106a and Thereby Up-Regulating KLF9
por: He, Xin, et al.
Publicado: (2020)

LncRNA SNHG12 promotes the malignant progression of melanoma by targeting miR-199b
por: Xie, Yijie, et al.
Publicado: (2022)

LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells
por: Li, Weidong, et al.
Publicado: (2019)

Correction to: LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells
por: Li, Weidong, et al.
Publicado: (2021)

LncRNA SNHG16 contributes to osteosarcoma progression by acting as a ceRNA of miR-1285-3p
por: Xiao, Xiao, et al.
Publicado: (2021)

LncRNA SNHG1 promotes tumor progression and cisplatin resistance through epigenetically silencing miR-381 in breast cancer
por: Zhang, Mingkun, et al.
Publicado: (2021)

The prognostic value of lncRNA SNHG6 in cancer patients
por: Shen, Haixiang, et al.
Publicado: (2020)

LncRNA SNHG6 role in clinicopathological parameters in cancers
por: Khan, Khushbukhat, et al.
Publicado: (2023)

Exosome-mediated transfer of lncRNA-SNHG14 promotes trastuzumab chemoresistance in breast cancer
por: Dong, Huaying, et al.
Publicado: (2018)

Exosome-mediated transfer of lncRNA-SNHG14 promotes trastuzumab chemoresistance in breast cancer
por: Dong, Huaying, et al.
Publicado: (2022)

LncRNA SNHG11 facilitates tumor metastasis by interacting with and stabilizing HIF-1α
por: Xu, Linguo, et al.
Publicado: (2020)

Analysis of PANoptosis-Related LncRNA-miRNA-mRNA Network Reveals LncRNA SNHG7 Involved in Chemo-Resistance in Colon Adenocarcinoma
por: Huang, Jingjing, et al.
Publicado: (2022)

LncRNA SNHG3, a potential oncogene in human cancers
por: Xu, Bin, et al.
Publicado: (2020)

LncRNA SNHG1: role in tumorigenesis of multiple human cancers
por: Zeng, Huang, et al.
Publicado: (2023)

LncRNA SNHG7 promotes non-small cell lung cancer progression and cisplatin resistance by inducing autophagic activity
por: She, Kelin, et al.
Publicado: (2023)

Silencing of lncRNA CHRM3-AS2 Expression Exerts Anti-Tumour Effects Against Glioma via Targeting microRNA-370-5p/KLF4
por: Wang, Dong, et al.
Publicado: (2022)

LncRNA-SNHG16 Silencing Inhibits Prostate Carcinoma Cell Growth, Downregulate GLUT1 Expression and Reduce Glucose Uptake
por: Shao, Mingfeng, et al.
Publicado: (2020)

LncRNA SNHG5 Promotes Proliferation of Glioma by Regulating miR-205-5p/ZEB2 Axis
por: Meng, Xiangrui, et al.
Publicado: (2019)

LncRNA SNHG10 increases the methylation of miR-218 gene to promote glucose uptake and cell proliferation in osteosarcoma
por: He, Pan, et al.
Publicado: (2020)

LncRNA CRNDE and lncRNA SNHG7 are Promising Biomarkers for Prognosis in Synchronous Colorectal Liver Metastasis Following Hepatectomy
por: Zhang, Peixian, et al.
Publicado: (2020)

lncRNA SNHG16 is associated with proliferation and poor prognosis of pediatric neuroblastoma
por: Yu, Yongbo, et al.
Publicado: (2019)

LncRNA SNHG15: A new budding star in human cancers
por: Shuai, You, et al.
Publicado: (2019)

LncRNA SNHG12 in extracellular vesicles derived from carcinoma-associated fibroblasts promotes cisplatin resistance in non-small cell lung cancer cells
por: Tan, Deli, et al.
Publicado: (2022)

lncRNA small nucleolar RNA host gene 20 predicts poor prognosis in glioma and promotes cell proliferation by silencing P21
por: Li, Xiang-Sheng, et al.
Publicado: (2019)

Retraction: LncRNA SNHG5 regulates the cell viability and apoptosis of glioma cells by the miR-1297/KPNA2 axis
por: Fisher, Laura
Publicado: (2021)

LncRNA SNHG7 Regulates Gastric Cancer Progression by miR-485-5p
por: Zhao, Zhongsong, et al.
Publicado: (2021)

lncRNA SNHG7 affects malignant tumor behaviors through downregulation of EZH2 in uveal melanoma cell lines
por: Wu, Xue, et al.
Publicado: (2020)

Up-regulation of LncRNA SNHG20 Predicts Poor Prognosis in Hepatocellular Carcinoma
por: Zhang, Dongyan, et al.
Publicado: (2016)

The prognostic value of lncRNA SNHG1 in cancer patients: a meta-analysis
por: Dong, Bingzi, et al.
Publicado: (2019)

LncRNA SNHG16 as a potential biomarker and therapeutic target in human cancers
por: Xiao, Yuhang, et al.
Publicado: (2020)

LncRNA SNHG1 was down-regulated after menopause and participates in postmenopausal osteoporosis
por: Huang, Shuaihao, et al.
Publicado: (2019)

SNHG12: An LncRNA as a Potential Therapeutic Target and Biomarker for Human Cancer
por: Tamang, Suraksha, et al.
Publicado: (2019)

The prognostic value of lncRNA SNHG4 and its potential mechanism in liver cancer
por: Jiao, Yan, et al.
Publicado: (2020)

High expression of lncRNA-SNHG7 is associated with poor prognosis in hepatocellular carcinoma
por: Shen, An, et al.
Publicado: (2020)

LncRNA SNHG17 Contributes to Proliferation, Migration, and Poor Prognosis of Hepatocellular Carcinoma
por: Luo, Yue, et al.
Publicado: (2021)

LncRNA Snhg6 regulates the differentiation of MDSCs by regulating the ubiquitination of EZH2
por: Lu, Wei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v3kdllju5b5t47u3pnui3c5ist